Developer docs
API playgroundTry for free, no card

Search company profiles

Cardiologs

Full company profile

uuid0000ptj

Namestring
Cardiologs
Legal namestring
Cardiologs
Websiteurl
cardiologs.com
Company typeenum
Private
Founded yearint
2014
Descriptiontext

Cardiologs is a Paris-based medical AI company that builds deep learning-powered software for the analysis of electrocardiogram (ECG) data, with a focus on arrhythmia detection and Holter monitoring. Founded in 2014, the company developed the Cardiologs Holter Platform, which became the first FDA-cleared ECG analysis solution powered by deep learning technology. The platform processes over 200 million ECGs and supports diagnosis of more than two million patients per year, offering clinicians and diagnostic service providers a cloud-based tool to reduce the manual burden of ECG interpretation and accelerate cardiac diagnosis. The underlying technology combines clinically validated deep learning algorithms with cloud infrastructure, protected by four patents and validated through more than 20 peer-reviewed publications and abstracts.

The company serves two primary customer segments: healthcare institutions and cardiology clinics requiring ECG analysis and arrhythmia diagnostic support, and diagnostic service providers managing high volumes of remote cardiac monitoring and population health screening. The go-to-market motion is enterprise-focused, with quote-based annual subscription licensing for the software as a medical device. Since being acquired by Koninklijke Philips N.V., Cardiologs operates as a wholly-owned subsidiary within Philips Healthcare's ambulatory monitoring and diagnostics division, with the product distributed exclusively through Philips' global healthcare sales channel. This integration provides Cardiologs with global institutional reach, regulatory infrastructure, and brand credibility in the medical device market that would have been difficult to build independently. The leadership team includes co-founder and CEO Yann Fleureau, co-founder and CSO Jia Li, COO Nicolas Godin, CCO Motty Klots, and CTO Romain Pomier.

Short descriptiontext

Cardiologs, a Philips subsidiary based in Paris, develops the first FDA-cleared deep learning-powered ECG analysis platform for arrhythmia detection and Holter monitoring, serving hospitals, cardiology clinics, and diagnostic service providers globally through Philips' healthcare distribution channel.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersParis, France
HQ citystring
Paris
HQ countrystring
France
HQ regionstring
Europe
Markets served

Serves global market

Keyword5 values
AI ECG analysis, cardiac diagnostics software, arrhythmia detection platform, Holter monitoring solution, medical-grade deep learning
Industry3 codes
PRIMARYHLAHACAB
Cardiac Monitoring (ECG/Holter/Event/Patch, Loop Recorders)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Patient Monitoring, Wearables & Remote Diagnostics
SECONDARYHLALAGAB
Cardiology Telemedicine Platforms
Healthcare & Life Sciences/Telehealth Platforms/Specialty Telemedicine Platforms (e.g., dermatology, cardiology, neurology)
SECONDARYHLAKABAA
General Cardiology (Consultative)
NAICS code1 code
  • Software Publishers513210
SIC code2 codes
  • Services-Prepackaged Software7372
  • Services-Medical Laboratories8071
Product category
Cardiac Diagnostics Software
Social media profiles2 records
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1ECG Analysis Software Licensing
TypeSubscription Recurring
Description

Cardiologs provides AI-powered ECG analysis software as a medical device solution. The platform is distributed through Philips' healthcare channel as a professional healthcare tool, likely sold as a subscription or license to healthcare institutions and cardiology service providers.

philips.co.uk
Marketing channels3 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Technology or R&D, Personnel, Infrastructure, Marketing or Sales, Operations
Pricing details1 tier
1Enterprise healthcare licensing
ModelSubscriptionBilling cadenceAnnual
Notes

Quote-based pricing through Philips healthcare sales channel. No public pricing available.

philips.co.uk
GTM typeB2B
B2B
Offering typeSoftware
Software
Core offering1 text field

Cardiologs provides an AI-powered, FDA-cleared Holter ECG analysis platform that uses deep learning algorithms to detect arrhythmias and assist clinicians with cardiac diagnostics. The cloud-based software is sold to hospitals, cardiology clinics, and diagnostic service providers through Philips' healthcare distribution channel, helping reduce the burden of manual ECG interpretation and enabling faster, more scalable cardiology diagnoses.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • Tripled Holter activity within 2 years at ICPS using Cardiologs Holter
+2 more records
Product overview1 text field

Cardiologs, a Philips company, offers a unified ECG analysis platform centered on its FDA-cleared Cardiologs Holter Platform. The solution utilizes clinically validated deep learning AI to help reduce the burden of ECG analysis, making cardiology diagnostics scalable and accessible. The platform processes over 200 million ECGs and helps diagnose over two million patients per year, providing tools for clinicians and service providers globally.

Product and service1 record
1Cardiologs Holter Platform
CategoryCardiac Diagnostics Software
Description

The first FDA-cleared ECG analysis solution powered by deep learning technology. It helps clinicians diagnose arrhythmias by analyzing Holter ECG data with AI, reducing the burden of ECG analysis and enabling faster diagnoses for hospitals, cardiology clinics, and diagnostic service providers.

Scale indicator5 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierCoreTypeOEM/ Whitelabel/ Licensing Partner
Description

Philips acquired Cardiologs and operates it as a subsidiary brand within their healthcare division. Cardiologs ECG analysis software is sold and distributed through Philips' ambulatory monitoring and diagnostics portfolio, leveraging Philips' global healthcare distribution network, regulatory expertise, and brand credibility in medical devices.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Public US company behind the Zio patch ambulatory cardiac monitor, which combines a wearable patch with a cloud-based AI ECG analytics platform. Direct competitor to Cardiologs in AI-driven ambulatory arrhythmia detection, serving cardiology clinics and hospitals with a device-plus-software model.

TypeDirect peer
Description

AI-ECG company offering KardiaMobile consumer/clinical single-lead ECG devices and KardiaPro cloud platform for arrhythmia detection. Directly comparable to Cardiologs in deploying deep-learning ECG algorithms for arrhythmia screening and remote cardiac monitoring.

TypeDirect peer
Description

Maker of AI-enabled digital stethoscopes and handheld ECGs (CORE 500) with FDA-cleared AI algorithms for cardiac murmur and AFib detection. Comparable to Cardiologs through deep-learning ECG/sound analysis for arrhythmia and cardiac disease screening in clinical settings.

TypeDirect peer
Description

Acquired by Boston Scientific, Preventice offers BodyGuardian remote cardiac monitoring with AI-assisted ECG analysis. Direct competitor in ambulatory cardiac monitoring with cloud-based arrhythmia detection for hospitals and cardiology practices.

TypeDirect peer
Description

Acquired by Baxter, Bardy offers the Carnation Ambulatory Monitor (CAM) patch with cloud ECG analysis. Comparable to Cardiologs in ambulatory ECG capture paired with algorithmic arrhythmia interpretation for clinical diagnostics.

TypeBroad incumbent
Description

Large incumbent medical device and diagnostics company offering MUSE cardiology ECG management systems and broader cardiac care portfolio. Comparable as a broad incumbent embedding ECG management and increasingly AI-driven analysis into hospital workflows.

TypeBroad incumbent
Description

Global medtech incumbent with a cardiology portfolio spanning ECG, cardiac imaging, and diagnostic AI. Comparable as a broad incumbent competing for hospital cardiology IT and ECG analytics budgets alongside specialty AI-ECG vendors like Cardiologs.

TypeEmerging player
Description

AI-driven non-invasive cardiac diagnostics company using CT-derived FFR analysis for coronary disease. Comparable as an emerging AI-cardiology diagnostics vendor targeting the same cardiology enterprise buyer, though focused on imaging rather than ECG.

TypeEmerging player
Description

Developer of the Cardea Solo wearable ECG sensor and associated AI-based arrhythmia analysis platform. Comparable as a smaller emerging player in ambulatory ECG + AI analytics competing for cardiology clinic adoption.

TypeEmerging player
Description

Compact 12-lead ECG (PCA 500) with cloud platform and AI-assisted interpretation, targeting both clinical and consumer/remote use. Comparable as an emerging AI-ECG vendor pairing a device with cloud analytics for distributed cardiac monitoring.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers1 record

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability1 record

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles5 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds5 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors9 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Cardiologs

Cardiac Diagnostics Softwarecardiologs.com

Cardiologs, a Philips subsidiary based in Paris, develops the first FDA-cleared deep learning-powered ECG analysis platform for arrhythmia detection and Holter monitoring, serving hospitals, cardiology clinics, and diagnostic service providers globally through Philips' healthcare distribution channel.

What Cardiologs does

Cardiologs is a Paris-based medical AI company that builds deep learning-powered software for the analysis of electrocardiogram (ECG) data, with a focus on arrhythmia detection and Holter monitoring. Founded in 2014, the company developed the Cardiologs Holter Platform, which became the first FDA-cleared ECG analysis solution powered by deep learning technology. The platform processes over 200 million ECGs and supports diagnosis of more than two million patients per year, offering clinicians and diagnostic service providers a cloud-based tool to reduce the manual burden of ECG interpretation and accelerate cardiac diagnosis. The underlying technology combines clinically validated deep learning algorithms with cloud infrastructure, protected by four patents and validated through more than 20 peer-reviewed publications and abstracts.

The company serves two primary customer segments: healthcare institutions and cardiology clinics requiring ECG analysis and arrhythmia diagnostic support, and diagnostic service providers managing high volumes of remote cardiac monitoring and population health screening. The go-to-market motion is enterprise-focused, with quote-based annual subscription licensing for the software as a medical device. Since being acquired by Koninklijke Philips N.V., Cardiologs operates as a wholly-owned subsidiary within Philips Healthcare's ambulatory monitoring and diagnostics division, with the product distributed exclusively through Philips' global healthcare sales channel. This integration provides Cardiologs with global institutional reach, regulatory infrastructure, and brand credibility in the medical device market that would have been difficult to build independently. The leadership team includes co-founder and CEO Yann Fleureau, co-founder and CSO Jia Li, COO Nicolas Godin, CCO Motty Klots, and CTO Romain Pomier.

Cardiologs firmographics

Firmographics
Name
Cardiologs
Legal name
Cardiologs
Website
https://cardiologs.com
Company type
Private
Founded year
2014
Operating status
Operating
Headcount range
51–100 employees
Short description
Cardiologs, a Philips subsidiary based in Paris, develops the first FDA-cleared deep learning-powered ECG analysis platform for arrhythmia detection and Holter monitoring, serving hospitals, cardiology clinics, and diagnostic service providers globally through Philips' healthcare distribution channel.
Ownership category
akta.pro rank

Cardiologs industry classification

Industry
Product category
Cardiac Diagnostics Software
NAICS
Software Publishers (513210)
SIC
Services-Prepackaged Software (7372), Services-Medical Laboratories (8071)
akta.pro industry
PRIMARYHLAHACAB
Cardiac Monitoring (ECG/Holter/Event/Patch, Loop Recorders)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Patient Monitoring, Wearables & Remote Diagnostics
SECONDARYHLALAGAB
Cardiology Telemedicine Platforms
Healthcare & Life Sciences/Telehealth Platforms/Specialty Telemedicine Platforms (e.g., dermatology, cardiology, neurology)
SECONDARYHLAKABAA
General Cardiology (Consultative)

Keywords

  • AI ECG analysis
  • Cardiac diagnostics software
  • Arrhythmia detection platform
  • Holter monitoring solution
  • Medical-grade deep learning

Where Cardiologs is headquartered

Location

Headquarters

HQ city
Paris
HQ country
France
HQ region
Europe

Markets served

Cardiologs business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Technology or R&D, Personnel, Infrastructure, Marketing or Sales, Operations

Revenue model

  1. ECG Analysis Software Licensing: Cardiologs provides AI-powered ECG analysis software as a medical device solution. The platform is distributed through Philips' healthcare channel as a professional healthcare tool, likely sold as a subscription or license to healthcare institutions and cardiology service providers.

Pricing tiers

ModelBillingPrice
SubscriptionAnnualEnterprise healthcare licensing

Go-to-market motion1 record

Distribution channels1 record

Marketing channels3 records

Cardiologs product offering

Product offering

Core offering

Cardiologs provides an AI-powered, FDA-cleared Holter ECG analysis platform that uses deep learning algorithms to detect arrhythmias and assist clinicians with cardiac diagnostics. The cloud-based software is sold to hospitals, cardiology clinics, and diagnostic service providers through Philips' healthcare distribution channel, helping reduce the burden of manual ECG interpretation and enabling faster, more scalable cardiology diagnoses.

Product overview

Cardiologs, a Philips company, offers a unified ECG analysis platform centered on its FDA-cleared Cardiologs Holter Platform. The solution utilizes clinically validated deep learning AI to help reduce the burden of ECG analysis, making cardiology diagnostics scalable and accessible. The platform processes over 200 million ECGs and helps diagnose over two million patients per year, providing tools for clinicians and service providers globally.

Differentiator

Problem solved

Functional benefit

Products and services

  • Cardiologs Holter Platform The first FDA-cleared ECG analysis solution powered by deep learning technology. It helps clinicians diagnose arrhythmias by analyzing Holter ECG data with AI, reducing the burden of ECG analysis and enabling faster diagnoses for hospitals, cardiology clinics, and diagnostic service providers.

Quantifiable outcome

  • Tripled Holter activity within 2 years at ICPS using Cardiologs Holter
  • +2 more outcomes

Companies that use Cardiologs

Customer profile

Named customers1 record

Segments2 records

Ideal customer profiles2 records

Cardiologs technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability1 record

Feature3 records

Cardiologs partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • PhilipscoreOEM/ Whitelabel/ Licensing PartnerPhilips acquired Cardiologs and operates it as a subsidiary brand within their healthcare division. Cardiologs ECG analysis software is sold and distributed through Philips' ambulatory monitoring and diagnostics portfolio, leveraging Philips' global healthcare distribution network, regulatory expertise, and brand credibility in medical devices.

Scale indicators5 records

Recent moves6 records

Expansion highlights4 records

Cardiologs competitors and assessment

Company assessment

Direct peers

  • iRhythm Technologies: Public US company behind the Zio patch ambulatory cardiac monitor, which combines a wearable patch with a cloud-based AI ECG analytics platform. Direct competitor to Cardiologs in AI-driven ambulatory arrhythmia detection, serving cardiology clinics and hospitals with a device-plus-software model.
  • AliveCor: AI-ECG company offering KardiaMobile consumer/clinical single-lead ECG devices and KardiaPro cloud platform for arrhythmia detection. Directly comparable to Cardiologs in deploying deep-learning ECG algorithms for arrhythmia screening and remote cardiac monitoring.
  • Eko Health: Maker of AI-enabled digital stethoscopes and handheld ECGs (CORE 500) with FDA-cleared AI algorithms for cardiac murmur and AFib detection. Comparable to Cardiologs through deep-learning ECG/sound analysis for arrhythmia and cardiac disease screening in clinical settings.
  • Preventice Solutions (Boston Scientific): Acquired by Boston Scientific, Preventice offers BodyGuardian remote cardiac monitoring with AI-assisted ECG analysis. Direct competitor in ambulatory cardiac monitoring with cloud-based arrhythmia detection for hospitals and cardiology practices.
  • Bardy Diagnostics (Baxter): Acquired by Baxter, Bardy offers the Carnation Ambulatory Monitor (CAM) patch with cloud ECG analysis. Comparable to Cardiologs in ambulatory ECG capture paired with algorithmic arrhythmia interpretation for clinical diagnostics.

Broad incumbents

  • GE HealthCare: Large incumbent medical device and diagnostics company offering MUSE cardiology ECG management systems and broader cardiac care portfolio. Comparable as a broad incumbent embedding ECG management and increasingly AI-driven analysis into hospital workflows.
  • Siemens Healthineers: Global medtech incumbent with a cardiology portfolio spanning ECG, cardiac imaging, and diagnostic AI. Comparable as a broad incumbent competing for hospital cardiology IT and ECG analytics budgets alongside specialty AI-ECG vendors like Cardiologs.

Emerging players

  • HeartFlow: AI-driven non-invasive cardiac diagnostics company using CT-derived FFR analysis for coronary disease. Comparable as an emerging AI-cardiology diagnostics vendor targeting the same cardiology enterprise buyer, though focused on imaging rather than ECG.
  • Cardiac Insight: Developer of the Cardea Solo wearable ECG sensor and associated AI-based arrhythmia analysis platform. Comparable as a smaller emerging player in ambulatory ECG + AI analytics competing for cardiology clinic adoption.
  • QT Medical: Compact 12-lead ECG (PCA 500) with cloud platform and AI-assisted interpretation, targeting both clinical and consumer/remote use. Comparable as an emerging AI-ECG vendor pairing a device with cloud analytics for distributed cardiac monitoring.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Cardiologs social profiles

Digital presence

Cardiologs financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Cardiologs leadership team

Management profile

Number of profiles

Profiles5 records

Cardiologs funding detail

Funding detail

Funding overview

Funding rounds5 records

Investors9 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Cardiologs M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Cardiologs

What does Cardiologs do?

Cardiologs provides an AI-powered, FDA-cleared Holter ECG analysis platform that uses deep learning algorithms to detect arrhythmias and assist clinicians with cardiac diagnostics. The cloud-based software is sold to hospitals, cardiology clinics, and diagnostic service providers through Philips' healthcare distribution channel, helping reduce the burden of manual ECG interpretation and enabling faster, more scalable cardiology diagnoses.

Is Cardiologs a public or private company?

Cardiologs is a private company. It is classified as corporate owned and is currently operating.

When was Cardiologs founded?

Cardiologs was founded in 2014. It employs 51 to 100 people.

Where is Cardiologs based?

Cardiologs is headquartered in Paris, France, in the Europe region.

How does Cardiologs make money?

One revenue line is on record: ECG Analysis Software Licensing.

Who are Cardiologs's main competitors?

Direct peers on record are iRhythm Technologies, AliveCor, Eko Health, Preventice Solutions (Boston Scientific) and Bardy Diagnostics (Baxter). Broad incumbents are GE HealthCare and Siemens Healthineers. Emerging players are HeartFlow, Cardiac Insight and QT Medical.

Does Cardiologs have an API?

No public API is recorded for Cardiologs.

What industry is Cardiologs in?

Cardiologs's product category is Cardiac Diagnostics Software. Its primary akta.pro industry code is HLAHACAB, Cardiac Monitoring (ECG/Holter/Event/Patch, Loop Recorders), with a secondary code of HLALAGAB, Cardiology Telemedicine Platforms. Its NAICS code is 513210 and its SIC code is 7372.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Coherent Market InsightsCardiovascular Monitoring And Diagnostic Devices Market SizeThe global cardiovascular monitoring and diagnostic devices market is projected to grow from USD 3,627.7 million in 2025 to USD 7,437.2 million by 2032, driven by rising chronic disease prevalence and strategic acquisitions. Key industry developments include Abbott's AVEIR pacemaker study results, Philips' acquisition of Cardiologs, and Masimo's FDA clearance for its Radius VSM monitor.PR NewswireStudy Demonstrates that Cardiologs' AI Dramatically Reduces Inconclusive Apple Watch ECGsCardiologs' deep learning AI reduced inconclusive Apple Watch ECG 2.0 results to 0% in a study of 101 patients, while maintaining accuracy. The study, presented at EHRA 2022, found Apple Watch ECG 2.0 yielded inconclusive diagnoses for 19% of recordings. The results aim to save physicians time and reduce missed arrhythmia detection.PR NewswireCardiologs' AI Receives 510(k) Clearance for Pediatric UseCardiologs has received 510(k) clearance from the U.S. Food and Drug Administration to expand its AI-powered cardiac diagnostics platform for pediatric use, making it the first AI ECG algorithm cleared for children under 18. The expanded authorization was based on improved deep learning performance demonstrated across a global sample of 10,000 EKG readings, showing a 14% improvement in arrhythmia sensitivity and a 48% reduction in false positives compared to the previous model. Cardiologs also announced it is being acquired by healthcare technology leader Royal Philips, which plans to leverage its global footprint to accelerate adoption of the technology worldwide.Les Echos​Philips s’offre la medtech CardiologsPhilips has acquired the French medtech startup Cardiologs to expand its cardiology portfolio, following its earlier purchase of BioTelemetry. Cardiologs, known for its AI-based ECG analysis software, had raised nearly €19 million since its founding and employs 70 people. The acquisition allows Philips to leverage its global network to accelerate the commercial deployment of Cardiologs' solution.PhilipsPhilips to expand its cardiac diagnostics and monitoring portfolio with the acquisition of CardiologsPhilips signed an agreement to acquire Cardiologs, a France-based medical technology company focused on AI and cloud-based cardiac diagnostics. The acquisition is expected to be completed in the coming months, with financial details not disclosed. Cardiologs' technology, built on over 20 million ECG recordings, will complement Philips' cardiac care portfolio.GlobeNewswirePhilips to expand its cardiac diagnostics and monitoring portfolio with the acquisition of CardiologsRoyal Philips has signed an agreement to acquire Cardiologs, a France-based medical technology company specializing in AI-driven cardiac diagnostics and monitoring. The transaction is expected to close in the coming months, subject to customary conditions, with financial details undisclosed. This acquisition aims to strengthen Philips' cardiac care portfolio by integrating Cardiologs' ECG analysis applications and machine learning algorithms into its existing health technology offerings.PR NewswireCardiologs' AI Improves Services for Cardiologists at Three European Medical CentersCardiologs, an AI cardiology diagnostics company, has deployed its deep learning platform at three medical centers in France — Pasteur Clinic in Toulouse, Ambroise Paré Clinic in Neuilly-sur-Seine, and Cardioréliance – Centre Cardiologique d'Orléans — to support automated electrocardiogram analysis. The deployments, which began in March 2020 and January 2021, have resulted in significant operational improvements including reduced ECG processing times, a 40% increase in Holter data analyses at Pasteur Clinic, and fewer false positives for clinicians. The company states the platform has enabled remote collaboration and increased examination capacity during the COVID-19 pandemic.AiThorityCardiologs Unveils New Solution to Enable Use of Smartwatches for Remote Patient MonitoringCardiologs announced its RPM platform for remote cardiac monitoring via smartwatches, debuting at Heart Rhythm 2021 in Boston. The platform automates ECG data sharing and triage, addressing the decentralized data challenge. It aims to enable real-time precision medicine in cardiac practices.PR NewswireCardiologs Unveils New Solution to Enable Use of Smartwatches for Remote Patient MonitoringCardiologs, an AI cardiology diagnostics company, announced the launch of Cardiologs RPM on July 21, 2021, a new remote patient monitoring platform designed to enable the clinical use of smartwatch-captured ECG data for cardiac care. The platform addresses a growing challenge where the volume of smartwatch ECG recordings creates an overwhelming, decentralized, and non-billable data flow that physicians struggle to manage. Cardiologs RPM includes a patient mobile app for automatic data transfer and a cloud-based physician platform to centralize, triage, and streamline ECG review with an integrated billing mechanism.PR NewswireNew Study Published in JACC Clinical EP Validates that Cardiologs' AI Eliminates Nearly Two-Thirds of False Positives in Remote Monitoring for Atrial FibrillationCardiologs announced that results of a clinical study conducted in collaboration with Valley Health System have been published in JACC Clinical EP, showing their AI-based ECG analysis solution significantly reduces false positive atrial fibrillation detection in remote cardiac monitoring. The study tracked 425 patients with implantable loop recorders and evaluated 1,500 AFib episodes, finding that the AI eliminated up to 66% of false positives and achieved a positive predictive value of 75%. Publication of these results validates Cardiologs' solution for reducing the clinical burden on electrophysiologists managing remote cardiac monitoring patients.